Лекарственные Препараты

Astellas Pharma to acquire Propella Therapeutic...

Astellas Pharmaceuticals Establishes Open Innov...

Astellas licenses 4DMT’s AAV vector for ophthal...

FDA Grants Full Approval for Astellas Pharma's ...

US FDA approves Astellas Pharma pill for menopa...

Home | Astellas Pharma Canada, Inc.

Astellas Pharma

Astellas Sues Over New Myrbetriq Patent to Reca...

Astellas Pharma on LinkedIn: 医薬品の枠を超えた...

Главная | Astellas Pharma Russia

Astellas, University of Tokyo extend partnershi...

About | Astellas Pharma Ltd

Astellas Pharma Inc. (4503N.MX) stock price, ne...

Astellas' Prostate Cancer Drug Available In Jap...

Astellas Offloads 5 Legacy Products to Germany’...

Japan's Astellas sees cancer drug fueling 29% p...

Astellas Pharma Joins Record Bond Sales by Japa...

Astellas

Astellas Pharma: A Contrarian Investment (OTCMK...

Astellas Home page | Astellas Pharma Inc.

Astellas Home page | Astellas Pharma Inc.

Атлас лекарственных растений - YouTube

Astellas gets FDA priority review for gastric c...

FDA Approves Astellas’ Non-hormonal Menopause T...

Pharmaceutical Technology

Asia Business Daily on Twitter: "Astellas Pharm...

China Formally Arrests Japanese Employee of Dru...

Главная | Astellas Pharma Russia

Astellas Pharma Projects :: Photos, videos, log...

Astellas Pharma US on LinkedIn: FDA Grants Prio...

FDA blocks Astellas’ Claudin cancer drug over m...

Astellas Trains Sights On Iveric Bio In $5.9 Bi...

Astellas Pharma EMEA celebrates its 10th annive...

Astellas introduces sustainable community initi...

Astellas Pharma - Global Web Site on Behance